Alan Hoffmann
Founder at Alan Hoffmann CPA PC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tom Zoda | M | - |
Cognitive Research Corp.
 Cognitive Research Corp. Miscellaneous Commercial ServicesCommercial Services Cognitive Research Corp. develops new medicines and therapies to improve mental health and neurological disorders. The company is based in St. Petersburg, FL. The company was founded in 2006 by Gary G. Kay, Steven Horohonich, Thomas Hochadel, Thomas Crook. Chip Gordon Gillooly has been the CEO of the company since 2022. | - |
| Thomas Hochadel | M | - |
Cognitive Research Corp.
Cognitive Research Corp. Miscellaneous Commercial ServicesCommercial Services Cognitive Research Corp. develops new medicines and therapies to improve mental health and neurological disorders. The company is based in St. Petersburg, FL. The company was founded in 2006 by Gary G. Kay, Steven Horohonich, Thomas Hochadel, Thomas Crook. Chip Gordon Gillooly has been the CEO of the company since 2022. | 18 years |
| Gary G. Kay | M | - |
Cognitive Research Corp.
Cognitive Research Corp. Miscellaneous Commercial ServicesCommercial Services Cognitive Research Corp. develops new medicines and therapies to improve mental health and neurological disorders. The company is based in St. Petersburg, FL. The company was founded in 2006 by Gary G. Kay, Steven Horohonich, Thomas Hochadel, Thomas Crook. Chip Gordon Gillooly has been the CEO of the company since 2022. | 18 years |
| Jeffrey Williams | M | - |
Cognitive Research Corp.
Cognitive Research Corp. Miscellaneous Commercial ServicesCommercial Services Cognitive Research Corp. develops new medicines and therapies to improve mental health and neurological disorders. The company is based in St. Petersburg, FL. The company was founded in 2006 by Gary G. Kay, Steven Horohonich, Thomas Hochadel, Thomas Crook. Chip Gordon Gillooly has been the CEO of the company since 2022. | 2 years |
| Patrick Dunnigan | M | - |
Cognitive Research Corp.
Cognitive Research Corp. Miscellaneous Commercial ServicesCommercial Services Cognitive Research Corp. develops new medicines and therapies to improve mental health and neurological disorders. The company is based in St. Petersburg, FL. The company was founded in 2006 by Gary G. Kay, Steven Horohonich, Thomas Hochadel, Thomas Crook. Chip Gordon Gillooly has been the CEO of the company since 2022. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas C. LaVoy | M | 64 |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | 13 years |
| Lori Woods | F | 61 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| Mark Austin | M | 37 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| Jennifer Streeter | F | 55 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| Peter Skanavis | M | - |
University of Wisconsin-Milwaukee
| 10 years |
| Krista Cline | F | 42 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| Johan Spoor | M | 52 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| Brien Ragle | M | 54 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | 10 years |
| Matthew P. Branson | M | 47 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| Philip J. Vitale | M | 78 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | 9 years |
| Ammar Malhas | M | 65 |
University of Wisconsin-Milwaukee
| 5 years |
| Cary Marc Klivan | M | - |
Pricewaterhouse LLP
| 4 years |
| Imad Mohammad Abdel Khaleq | M | 61 |
University of Wisconsin-Milwaukee
| 4 years |
| Kenneth Grondin | M | 61 |
Pricewaterhouse LLP
| 8 years |
| Paul Knollmeyer | M | - |
Pricewaterhouse LLP
| 5 years |
| Steven R. Saltzman | M | 60 |
Pricewaterhouse LLP
| 3 years |
| Stephen P. Gibson | M | 58 |
Pricewaterhouse LLP
| 7 years |
| Mike Hoerres | M | - |
University of Wisconsin-Milwaukee
| 2 years |
| Rick Sayles | M | - |
Pricewaterhouse LLP
| 4 years |
| Deanna Goodwin | F | 59 |
Pricewaterhouse LLP
| 6 years |
| Brian J. Dick | M | 67 |
Pricewaterhouse LLP
| 11 years |
| David Blackley | M | 62 |
Pricewaterhouse LLP
| - |
| Brian Bales | M | 61 |
Pricewaterhouse LLP
| 2 years |
| Daniel J. Vogel | M | - |
Pricewaterhouse LLP
| 4 years |
| Steven L. Beal | M | 65 |
Pricewaterhouse LLP
| 7 years |
| Giovanni Palacardo | M | - |
Pricewaterhouse LLP
| 3 years |
| Frank Morich | M | 69 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| James Taylor | M | 57 |
Pricewaterhouse LLP
| 3 years |
| Ned Shadek | M | - |
Pricewaterhouse LLP
| 3 years |
| Ed Fitzpatrick | M | 57 |
Pricewaterhouse LLP
| 10 years |
| Edward M. McNamara | M | 59 |
Pricewaterhouse LLP
| 7 years |
| James Spellmeyer | M | 66 |
Pricewaterhouse LLP
| 7 years |
| Siva Yam | M | - |
University of Wisconsin-Milwaukee
| 3 years |
| Sam Khoury | M | 69 |
University of Wisconsin-Milwaukee
| 2 years |
| Lisa Lauer | F | - |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| Donna Fort | F | - |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| Judy Heun | F | 57 |
University of Wisconsin-Milwaukee
| 4 years |
| Timothy G. Schaefer | M | - |
University of Wisconsin-Milwaukee
| 4 years |
| Lester S. Fuwa | M | - |
Pricewaterhouse LLP
| 9 years |
| J. S. Gamble | M | - |
Pricewaterhouse LLP
| 6 years |
| Martin Joseph Braddock | M | 62 |
Pricewaterhouse LLP
| - |
| Brien Brown | M | - |
Pricewaterhouse LLP
| - |
| Jerry R. Banks | M | - |
Pricewaterhouse LLP
| 2 years |
| Neil Porteous Gilchrist | M | 56 |
Pricewaterhouse LLP
| - |
| Philip Wright | M | 70 |
Pricewaterhouse LLP
| 11 years |
| Bob Doyle | M | - |
Pricewaterhouse LLP
| 4 years |
| Karen McLoughlin | F | 59 |
Pricewaterhouse LLP
| 6 years |
| Assaad W. Razzouk | M | - |
Pricewaterhouse LLP
| 5 years |
| Patrick John Retzer | M | - |
University of Wisconsin-Milwaukee
| 1 years |
| David Barr | M | 60 |
Pricewaterhouse LLP
| 4 years |
| Michael J. Welsh | M | - |
Pricewaterhouse LLP
| 5 years |
| Timothy J. Andrews | M | - |
Pricewaterhouse LLP
| - |
| Eileen M. Leary | F | - |
Pricewaterhouse LLP
| 4 years |
| William C. Kelly | M | 65 |
Pricewaterhouse LLP
| 5 years |
| Kenton Sicchitano | M | 79 |
Pricewaterhouse LLP
| 19 years |
| Iggy Smetek | M | - |
University of Wisconsin-Milwaukee
| 4 years |
| John D. Diederich | M | 71 |
Pricewaterhouse LLP
| 11 years |
| Donald Rober Bessler | M | - |
Pricewaterhouse LLP
| 5 years |
| David Gregory Herro | M | - |
University of Wisconsin-Milwaukee
| 1 years |
| John Gavin | M | 68 |
Pricewaterhouse LLP
| 10 years |
| John M. Garrow | M | - |
Pricewaterhouse LLP
| 6 years |
| Joseph R. Sandoval | M | 60 |
Pricewaterhouse LLP
| 10 years |
| Joseph P. Joseph | M | - |
Pricewaterhouse LLP
| 5 years |
| Kevin Parker | M | 64 |
Pricewaterhouse LLP
| 5 years |
| Alan Edrick | M | 56 |
Pricewaterhouse LLP
| 9 years |
| Robert Williamson | M | 58 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| Edward Jepsen | M | 80 |
Pricewaterhouse LLP
| 19 years |
| Haag Sherman | M | 58 |
Pricewaterhouse LLP
| 1 years |
| Charles Sledge | M | 58 |
Pricewaterhouse LLP
| 7 years |
| Mary Stanek | F | 67 |
University of Wisconsin-Milwaukee
| 2 years |
| Russ J. Bell | M | - |
Pricewaterhouse LLP
| 4 years |
| James R. Fisher | M | 69 |
Pricewaterhouse LLP
| - |
| Maria Christina van der Sluijs-Plantz | F | - |
Pricewaterhouse LLP
| - |
| Dennis James Simonis | M | 67 |
Pricewaterhouse LLP
| 6 years |
| Richard S. Davis | M | 65 |
Pricewaterhouse LLP
| 11 years |
| James S. O'Donnell | M | - |
Pricewaterhouse LLP
| - |
| Dana C. Russell | M | 62 |
Pricewaterhouse LLP
| 3 years |
| Mark Hahn | M | 61 |
University of Wisconsin-Milwaukee
| 4 years |
| Cameron B. Olson | M | 60 |
Pricewaterhouse LLP
| 9 years |
| Barry W. Stewart | M | - |
Pricewaterhouse LLP
| 5 years |
| Wallace R. Cooney | M | 61 |
Pricewaterhouse LLP
| 12 years |
| Mary Ritchie | F | 67 |
Pricewaterhouse LLP
| 9 years |
| Clinton W. Walker | M | 61 |
Pricewaterhouse LLP
| 9 years |
| Thomas R. Pilholski | M | 68 |
Pricewaterhouse LLP
| 11 years |
| Don Radtke | M | - |
University of Wisconsin-Milwaukee
| 4 years |
| Andy Colyer | M | - |
Pricewaterhouse LLP
| - |
| Scott Craig | M | 61 |
Pricewaterhouse LLP
| 3 years |
| Todd N. Jordan | M | - |
Pricewaterhouse LLP
| 15 years |
| Jonathan Hunt | M | 57 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | - |
| Lawrence Judge | M | - |
Pricewaterhouse LLP
| 3 years |
| Lowell J. Hill | M | - |
Pricewaterhouse LLP
| 4 years |
| Ian John Brookes | M | 62 |
Pricewaterhouse LLP
| - |
| Edwin C. Ciskowski | M | - |
University of Wisconsin-Milwaukee
| 4 years |
| David Coulson Stonehouse | M | 69 |
Pricewaterhouse LLP
| - |
| Robert Joseph Fitzsimmons | M | - |
Pricewaterhouse LLP
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alan Hoffmann
- Personal Network
